secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2023-01-05T23:59:59+00:00
Accession:  0001104659-23-001400
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma enacts 1-for-20 reverse stock split to regain Nasdaq $1.00 bid compliance
--------------------------------------------------------------------------------

- 1-for-20 reverse split reduces outstanding shares from ~68.8M to ~3.4M.
- Company must maintain closing bid ≥$1.00 for 10 consecutive days by May 22, 2023 to comply with Nasdaq.
- Proportional adjustments to warrants, options, and equity plan pool; no fractional shares—cash in lieu.
- New CUSIP 054754858; shares continue trading under ticker AYTU on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000110465923001400/0001104659-23-001400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000110465923001400/tm231530d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-001400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer